2024
Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T
Mevenkamp J, Bruls Y, Mancilla R, Grevendonk L, Wildberger J, Brouwers K, Hesselink M, Schrauwen P, Hoeks J, Houtkooper R, Buitinga M, de Graaf R, Lindeboom L, Schrauwen-Hinderling V. Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T. Nature Communications 2024, 15: 9159. PMID: 39443469, PMCID: PMC11499639, DOI: 10.1038/s41467-024-53292-4.Peer-Reviewed Original ResearchConceptsPhysically active older adultsActive older adultsMetabolic healthHuman skeletal musclePhosphorous magnetic resonance spectroscopySedentary individualsOlder adultsStimulate mitochondrial biogenesisHealthSkeletal muscleMitochondrial biogenesisNAD+Physiological decreaseNADH contentNADHQuantify NADHClinical 3Magnetic resonance spectroscopy techniquesMR sequencesAdultsMeasurement reproducibility
1999
Cerebral Metabolism Measured Using Proton and Phosphorous Magnetic Resonance Spectroscopy (MRS) Following Hypoxia Ischemia (HI) and Administration of Allopurinol (ALLO) and Deferoxamine (DFO)
Peeters C, Van Den Tweel E, De Graaf R, Braun K, Nicolay K, Van Bel F, Groenendaal F. Cerebral Metabolism Measured Using Proton and Phosphorous Magnetic Resonance Spectroscopy (MRS) Following Hypoxia Ischemia (HI) and Administration of Allopurinol (ALLO) and Deferoxamine (DFO). Pediatric Research 1999, 45: 345-345. DOI: 10.1203/00006450-199904020-02053.Peer-Reviewed Original ResearchAdministration of allopurinolHypoxia-ischemiaPhosphorous magnetic resonance spectroscopyCerebral metabolismMagnetic resonance spectroscopyDeferoxamineIschemiaAllopurinolAdministration